540694 Stock Overview
ANG Lifesciences India Limited, a pharmaceutical company, engages in the manufacture and marketing of finished pharmaceuticals formulation in a dosage form of sterile dry powder injection vials in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
ANG Lifesciences India Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹56.74 |
| 52 Week High | ₹91.00 |
| 52 Week Low | ₹44.49 |
| Beta | 0.48 |
| 1 Month Change | 3.26% |
| 3 Month Change | -19.85% |
| 1 Year Change | -34.73% |
| 3 Year Change | 33.63% |
| 5 Year Change | 147.56% |
| Change since IPO | 47.76% |
Recent News & Updates
Recent updates
Shareholder Returns
| 540694 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -4.2% | -2.2% | -2.1% |
| 1Y | -34.7% | 55.3% | 45.3% |
Return vs Industry: 540694 underperformed the Indian Pharmaceuticals industry which returned 55.3% over the past year.
Return vs Market: 540694 underperformed the Indian Market which returned 45.3% over the past year.
Price Volatility
| 540694 volatility | |
|---|---|
| 540694 Average Weekly Movement | 5.9% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 540694's share price has been volatile over the past 3 months.
Volatility Over Time: 540694's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 545 | Rajesh Gupta | anglifesciences.com |
ANG Lifesciences India Limited, a pharmaceutical company, engages in the manufacture and marketing of finished pharmaceuticals formulation in a dosage form of sterile dry powder injection vials in India and internationally. The company’s products include various therapeutic categories, such as antibiotic, antiviral, antimalarial, antiulcer, carbapenem, corticosteroid, penicillin, and Beta-lactamase inhibitor. It also offers liquid injection vials, ampoules, PFS, hard and soft gelatin capsules, tablets, dry and liquid syrups, and suspension lotions.
ANG Lifesciences India Limited Fundamentals Summary
| 540694 fundamental statistics | |
|---|---|
| Market cap | ₹737.66m |
| Earnings (TTM) | -₹111.05m |
| Revenue (TTM) | ₹1.48b |
0.5x
P/S Ratio-6.7x
P/E RatioIs 540694 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 540694 income statement (TTM) | |
|---|---|
| Revenue | ₹1.48b |
| Cost of Revenue | ₹1.07b |
| Gross Profit | ₹409.48m |
| Other Expenses | ₹520.53m |
| Earnings | -₹111.05m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -8.50 |
| Gross Margin | 27.72% |
| Net Profit Margin | -7.52% |
| Debt/Equity Ratio | 84.3% |
How did 540694 perform over the long term?
See historical performance and comparison